News
The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...
Eli Lilly and Company (NYSE:LLY) is one of the 12 stocks that will make you rich in 10 years. On June 23, Truist Securities ...
VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...
Health and Me on MSN3d
Type 1 Diabetes Patients May Not Need Insulin To Survive With New Cell Treatment: StudyDiabetes affects many people in the world, type 1 diabetes being a condition that can affect anyone, causing them to be on ...
Everyday Health on MSN2d
Ditching Diet Soda Tied to Weight Loss and Higher Chance of Diabetes RemissionWomen with diabetes who were overweight or had obesity lost more weight and had greater odds of diabetes remission when ...
The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association's 85th ...
HealthDay on MSN1d
ADA: Insulin Efsitora Noninferior to Glargine for Reducing HbA1c in Adults With Type 2 DiabetesOnce-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated ...
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...
CHICAGO, June 21, 2025 /PRNewswire/ -- As the American Diabetes Association® (ADA) celebrates its 85th anniversary, it continues to fuel transformative progress in the fight to end diabetes—and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback